Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-FR
Language English French
Date Updated 2020-10-20 2020-09-28
Drug Identification Number 02495929 02495929
Brand name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Common or Proper name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CLAVULANIC ACID AMOXICILLIN CLAVULANIC ACID AMOXICILLIN
Strength(s) 200MG 1000MG 200MG 1000MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10PSOIJ CA 10PSOIJ CA
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Delay in shipping of the drug. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-10-19 2020-09-25
Estimated end date 2020-10-19 2020-11-13
Actual end date 2020-10-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments INVENTORY AVAILABLE AT WHOLESALER
Health Canada comments